analysts forecasts

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. RBC Capital raised IDEAYA Biosciences, Inc. (NASDAQ:IDYA) price target from $36 to $38. RBC Capital analyst...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Mizuho raised Chewy, Inc. (NYSE:CHWY) price target from $44 to $50. Mizuho analyst David Bellinger upgraded...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Tigress Financial raised Alphabet Inc. (NASDAQ:GOOGL) price target from $240 to $280. Tigress Financial...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. DA Davidson cut GitLab Inc. (NASDAQ:GTLB) price target from $50 to $45. DA Davidson analyst Lucky Schreiner...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised Alphabet Inc. (NASDAQ:GOOGL) price target from $220 to $260. Needham analyst Laura Martin...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Guggenheim raised Inventiva S.A. (NASDAQ:IVA) price target from $9 to $13. Guggenheim analyst Etzer Darout...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Piper Sandler raised Autodesk, Inc. (NASDAQ:ADSK) price target from $361 to $373. Piper Sandler analyst...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. UBS raised Wynn Resorts, Limited (NASDAQ:WYNN) price target from $101 to $147. UBS analyst Robin Farley...

Okta, Inc. (NASDAQ:OKTA) reported better-than-expected second-quarter financial results and raised its FY26 guidance above estimates on Tuesday. Okta reported second-quarter revenue of $728 million, beating analyst estimates of $712.01 million, according to Benzinga Pro. The cloud-native...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Goldman Sachs raised American Airlines Group Inc. (NASDAQ:AAL) price target from $8 to $10. Goldman Sachs...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. UBS raised Albemarle Corporation (NYSE:ALB) price target from $62 to $89. UBS analyst Joshua Spector...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BMO Capital raised Gold Fields Limited (NYSE:GFI) price target from $24 to $32. BMO Capital analyst Raj Ray...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Jefferies raised aTyr Pharma, Inc. (NASDAQ:ATYR) price target from $9 to $17. Jefferies analyst Roger Song...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Needham raised I-Mab (NASDAQ:IMAB) price target from $5 to $6. Needham analyst Gil Blum maintained a Buy...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. B of A Securities raised Keysight Technologies, Inc. (NYSE:KEYS) price target from $175 to $179. B of A...